(Q44480097)

English

Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet (English)

1 reference

Europe PubMed Central

3 December 2017

0 references

hypercholesterolemia

0 references

0 references

1 reference

based on heuristic

inferred from title

Giuseppe Derosa

1

1 reference

Europe PubMed Central

3 December 2017

author name string

Amedeo Mugellini

2

1 reference

Europe PubMed Central

3 December 2017

Leonardina Ciccarelli

3

1 reference

Europe PubMed Central

3 December 2017

Roberto Fogari

4

1 reference

Europe PubMed Central

3 December 2017

publication date

1 April 2003

1 reference

Europe PubMed Central

3 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

3 December 2017

25

1 reference

Europe PubMed Central

3 December 2017

4

1 reference

Europe PubMed Central

3 December 2017

1107-1122

1 reference

Europe PubMed Central

3 December 2017

Obesity, health services use, and health care costs among members of a health maintenance organization.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Science, medicine, and the future. Obesity treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of illness review of obesity: are the true costs realised?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Range of serum cholesterol values in the population developing coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvastatin: a review of its use in lipid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Waist circumference as a measure for indicating need for weight management.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with orlistat reduces cardiovascular risk in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lipid-lowering agents in the Dahl salt-sensitive rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin prevents development of hypertension in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of cholesterol reduction on BP response to mental stress in patients with high cholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Does lowering of cholesterol levels influence functional properties of large arteries?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Early and late effects of weight loss on lipoprotein metabolism in severe obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Orlistat, a new lipase inhibitor for the management of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980070-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80070-X

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44480097&oldid=2025300357"